Ever Supreme Bio Technology (6794) Shareholders Approve Lifting of Non-Compete Restrictions for Directors
At the annual shareholders' meeting held on May 20, 115, Ever Supreme Bio Technology approved the lifting of non-compete restrictions for specific directors, including Hsieh Hsiu-mei. This resolution applies during their term and has no material impact on the company's financial or business operations.
📋 Article Processing Timeline
- 📰 Published: May 21, 2026 at 06:31
- 🔍 Collected: May 21, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 21, 2026 at 07:07 (35 min after Collected)
Release Date: 115/05/21
Statement Date: 115/05/20
Statement Time: 17:00:07
Company Code: 6794
Company Name: Ever Supreme Bio Technology
Subject: Notice that the 115 annual shareholders' meeting passed the removal of non-compete restrictions for company directors.
Applicable Clause: Article 21
Date of occurrence: 115/05/20
Explanation:
1. Date of shareholders' meeting resolution: 115/05/20
2. Names and titles of directors permitted to engage in competitive behavior:
Director: Representative of Qi Teng Co., Ltd.: Hsieh Hsiu-mei
Director: Chang Chia-fang
Director: Ling Mei-hua
Independent Director: Chen Cheng-jen
Independent Director: Su Chun-yuan
3. Items permitted for competitive behavior: Positions currently held that relate to non-compete restrictions.
4. Period permitted for competitive behavior: During the term of service as a company director.
5. Resolution status (Explain voting results according to Article 209 of the Company Act): This proposal was passed with the approval of more than half of the voting rights present at the shareholders' meeting, where shareholders representing more than two-thirds of the total issued shares were in attendance.
6. Whether the permitted competitive behavior relates to business in Mainland China: Not applicable.
7. Company name and position held in the Mainland China business: Not applicable.
8. Address of the Mainland China business: Not applicable.
9. Operating items of the Mainland China business: Not applicable.
10. Impact on company's financial business: No material impact on the company's financial or business operations.
11. Investment amount and shareholding ratio if the director has invested in the Mainland China business: Not applicable.
12. Other matters to be specified: None.
Statement Date: 115/05/20
Statement Time: 17:00:07
Company Code: 6794
Company Name: Ever Supreme Bio Technology
Subject: Notice that the 115 annual shareholders' meeting passed the removal of non-compete restrictions for company directors.
Applicable Clause: Article 21
Date of occurrence: 115/05/20
Explanation:
1. Date of shareholders' meeting resolution: 115/05/20
2. Names and titles of directors permitted to engage in competitive behavior:
Director: Representative of Qi Teng Co., Ltd.: Hsieh Hsiu-mei
Director: Chang Chia-fang
Director: Ling Mei-hua
Independent Director: Chen Cheng-jen
Independent Director: Su Chun-yuan
3. Items permitted for competitive behavior: Positions currently held that relate to non-compete restrictions.
4. Period permitted for competitive behavior: During the term of service as a company director.
5. Resolution status (Explain voting results according to Article 209 of the Company Act): This proposal was passed with the approval of more than half of the voting rights present at the shareholders' meeting, where shareholders representing more than two-thirds of the total issued shares were in attendance.
6. Whether the permitted competitive behavior relates to business in Mainland China: Not applicable.
7. Company name and position held in the Mainland China business: Not applicable.
8. Address of the Mainland China business: Not applicable.
9. Operating items of the Mainland China business: Not applicable.
10. Impact on company's financial business: No material impact on the company's financial or business operations.
11. Investment amount and shareholding ratio if the director has invested in the Mainland China business: Not applicable.
12. Other matters to be specified: None.
FAQ
Why was the non-compete restriction lifted for directors?
To allow directors to fulfill other professional roles and incorporate external expertise into the company's management.
Does this change impact the company?
The company states that there is no material impact on its financial or business operations.